MYCN and cancer: Recently, suppression of MYC and MYCN expression and activity by BET inhibition has been shown in several types of human cancers (reviewed in Shi J et al., 2014 and Fu LL et al., 2015) [13, 14]; however, its effects on MYCL have not yet been well studied.